250 related articles for article (PubMed ID: 25601323)
61. Increased insulin-like growth factor binding protein-3 expression level in psoriatic tissue before and after systemic treatment with cyclosporine A and methotrexate.
Ozden MG; Ilter N; Suer OE; Solaktekin N; Gürer MA
Int J Dermatol; 2008 Nov; 47(11):1177-83. PubMed ID: 18986456
[TBL] [Abstract][Full Text] [Related]
62. Traditional systemic treatments have not fully met the needs of psoriasis patients: results from a national survey.
Nijsten T; Margolis DJ; Feldman SR; Rolstad T; Stern RS
J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):434-44. PubMed ID: 15761421
[TBL] [Abstract][Full Text] [Related]
63. Systemic treatment for moderate to severe psoriasis: estimates of failure rates and direct medical costs in a north-eastern US managed care plan.
Feldman SR; Evans C; Russell MW
J Dermatolog Treat; 2005 Feb; 16(1):37-42. PubMed ID: 15897166
[TBL] [Abstract][Full Text] [Related]
64. Swiss S1 Guidelines on the Systemic Treatment of Psoriasis Vulgaris.
Kolios AG; Yawalkar N; Anliker M; Boehncke WH; Borradori L; Conrad C; Gilliet M; Häusermann P; Itin P; Laffitte E; Mainetti C; French LE; Navarini AA
Dermatology; 2016; 232(4):385-406. PubMed ID: 27322375
[TBL] [Abstract][Full Text] [Related]
65. Methotrexate: improving safety profile.
Grills C; Burge S
Australas J Dermatol; 2006 Aug; 47(3):178-81. PubMed ID: 16866998
[TBL] [Abstract][Full Text] [Related]
66. [Therapy options for psoriasis in childhood and adolescence].
Zappel K; Sterry W; Blume-Peytavi U
J Dtsch Dermatol Ges; 2004 May; 2(5):329-42. PubMed ID: 16281521
[TBL] [Abstract][Full Text] [Related]
67. Nail psoriasis improvement in a patient treated with fumaric acid esters.
Vlachou C; Berth-Jones J
J Dermatolog Treat; 2007; 18(3):175-7. PubMed ID: 17538807
[TBL] [Abstract][Full Text] [Related]
68. [Biologics in the treatment of psoriasis].
Dissemond J; Grabbe S
MMW Fortschr Med; 2006 Sep; 148(38):42-4. PubMed ID: 17036963
[TBL] [Abstract][Full Text] [Related]
69. Proceedings of the Psoriasis Combination and Rotation Therapy Conference. Deer Valley, Utah, Oct. 7-9, 1994.
Menter MA; See JA; Amend WJ; Ellis CN; Krueger GG; Lebwohl M; Morison WL; Prystowsky JH; Roenigk HH; Shupack JL; Silverman AK; Weinstein GD; Yocum DE; Zanolli MD
J Am Acad Dermatol; 1996 Feb; 34(2 Pt 1):315-21. PubMed ID: 8642106
[No Abstract] [Full Text] [Related]
70. Evaluation of the effectiveness of childhood generalized pustular psoriasis treatment in 30 cases.
Juanqin G; Zhiqiang C; Zijia H
Pediatr Dermatol; 1998; 15(2):144-6. PubMed ID: 9572705
[No Abstract] [Full Text] [Related]
71. Effectiveness of systemic treatment agents on psoriatic nails: a comparative study.
Demirsoy EO; Kıran R; Salman S; Cağlayan C; Aktürk AS; Bayramgurler D; Bilen N
J Drugs Dermatol; 2013 Sep; 12(9):1039-43. PubMed ID: 24002153
[TBL] [Abstract][Full Text] [Related]
72. Management of pediatric psoriasis with acitretin: A review.
Subedi S; Yu Q; Chen Z; Shi Y
Dermatol Ther; 2018 Jan; 31(1):. PubMed ID: 29094450
[TBL] [Abstract][Full Text] [Related]
73. Anti-TNF-alpha therapy in childhood pustular psoriasis.
Pereira TM; Vieira AP; Fernandes JC; Antunes H; Basto AS
Dermatology; 2006; 213(4):350-2. PubMed ID: 17135745
[No Abstract] [Full Text] [Related]
74. HLA-G 14-bp polymorphism: a possible marker of systemic treatment response in psoriasis vulgaris? Preliminary results of a retrospective study.
Borghi A; Rizzo R; Corazza M; Bertoldi AM; Bortolotti D; Sturabotti G; Virgili A; Di Luca D
Dermatol Ther; 2014; 27(5):284-9. PubMed ID: 24909182
[TBL] [Abstract][Full Text] [Related]
75. [Systemic therapy in the treatment of psoriasis: drugs of prebiological era].
Kurilić M; Prpić-Massari L; Brajac I; Kastelan M
Lijec Vjesn; 2010; 132(7-8):246-51. PubMed ID: 20857811
[TBL] [Abstract][Full Text] [Related]
76. Cyclosporin in childhood psoriasis.
Perrett CM; Ilchyshyn A; Berth-Jones J
J Dermatolog Treat; 2003 Jun; 14(2):113-8. PubMed ID: 12775319
[TBL] [Abstract][Full Text] [Related]
77. Thrombocytopenia probably induced by acitretin.
García-Arpa M; López-Nieto M; Santiago Sánchez-Mateos JL; Sánchez-Caminero MP
Actas Dermosifiliogr; 2015 Oct; 106(8):692-3. PubMed ID: 26071907
[No Abstract] [Full Text] [Related]
78. Double trouble: therapeutic challenges in patients with both juvenile dermatomyositis and psoriasis.
Kim NN; Lio PA; Morgan GA; Jarvis JN; Pachman LM
Arch Dermatol; 2011 Jul; 147(7):831-5. PubMed ID: 21422326
[TBL] [Abstract][Full Text] [Related]
79. The use of folic acid supplementation in psoriasis patients receiving methotrexate: a survey in the United Kingdom.
Kirby B; Lyon CC; Griffiths CE; Chalmers RJ
Clin Exp Dermatol; 2000 Jun; 25(4):265-8. PubMed ID: 10971481
[TBL] [Abstract][Full Text] [Related]
80. Pemphigus vulgaris with plaque-type psoriasis successfully treated with cyclosporine monotherapy.
Rallis E; Stavropoulos P; Christofidou E; Rigopoulos D; Koumantaki-Mathioudaki E
Am J Clin Dermatol; 2011 Aug; 12(4):283-4. PubMed ID: 21668035
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
